본문 바로가기
KERD
논문KCI 등재

세포병리검사에서 쓸개관암종의 IMP3 발현과 진단적 가치

IMP3 Expression of the Cholangiocarcinoma in Cytology Specimen and Its Diagnostic Value

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류병리학

초록

Background : Pathologists occasionally have difficulty in distinguishing cholangiocarcinoma from benign reactive cells on the biliary cytology. We estimated the diagnostic value of insulinlike growth factor II mRNA binding protein 3 (IMP3) on biliary cytology specimens. Methods : We selected 40 patients who had undergone a biliary cytology examination and whose diagnoses were confirmed by biopsy. The IMP3 expression was evaluated by immunohistochemical staining in both the tissue and the cytology specimens. Their histologic diagnoses were cholangiocarcinoma (n = 34), high grade dysplasia (n = 2), low grade dysplasia (n = 1) and non-biliary tumor or no tumor (n = 3). Results : On the histology, all the cases of cholangiocarcinoma or high grade dysplasia were positive for IMP3 (36/36). The low grade dysplasia or the normal bile ducts in the other 4 cases were negative for IMP3 (0/4). Of the 36 cases diagnosed as cholangiocarcinoma or high grade dysplasia histologically, 29 cases were positive for IMP3 on the cytology (29/36; sensitivity, 80.6%). Of the 4 cases without cholangiocarcinoma or high grade dysplasia, 1 case was weakly positive for IMP3 on the cytology. The histologic diagnosis of this case was hepatocellular carcinoma. Except for this hepatocellular carcinoma case, the specificity of IMP3 on the cytology was 100%. Conclusions : IMP3 is a useful diagnostic marker for cholangiocarcinoma on cytology.

Abstract

Background : Pathologists occasionally have difficulty in distinguishing cholangiocarcinoma from benign reactive cells on the biliary cytology. We estimated the diagnostic value of insulinlike growth factor II mRNA binding protein 3 (IMP3) on biliary cytology specimens. Methods : We selected 40 patients who had undergone a biliary cytology examination and whose diagnoses were confirmed by biopsy. The IMP3 expression was evaluated by immunohistochemical staining in both the tissue and the cytology specimens. Their histologic diagnoses were cholangiocarcinoma (n = 34), high grade dysplasia (n = 2), low grade dysplasia (n = 1) and non-biliary tumor or no tumor (n = 3). Results : On the histology, all the cases of cholangiocarcinoma or high grade dysplasia were positive for IMP3 (36/36). The low grade dysplasia or the normal bile ducts in the other 4 cases were negative for IMP3 (0/4). Of the 36 cases diagnosed as cholangiocarcinoma or high grade dysplasia histologically, 29 cases were positive for IMP3 on the cytology (29/36; sensitivity, 80.6%). Of the 4 cases without cholangiocarcinoma or high grade dysplasia, 1 case was weakly positive for IMP3 on the cytology. The histologic diagnosis of this case was hepatocellular carcinoma. Except for this hepatocellular carcinoma case, the specificity of IMP3 on the cytology was 100%. Conclusions : IMP3 is a useful diagnostic marker for cholangiocarcinoma on cytology.

참고문헌 (19)

  1. Nielsen FC, "A family of IGF-II mRNA binding proteins(IMP)involved in RNA trafficking", Scand J Clin Lab Invest Suppl, 234, pp.93~99 (2001)
  2. Mueller-Pillasch F, "Expression of the highly conserved RNA binding protein KOC in embryogenesis", Mech Dev, 88, pp.95~99 (1999)
  3. Vikesaa J, "RNA-binding IMPs promote cell adhesion and invadopodia formation", EMBO J, 25, pp.1456~1468 (2006)
  4. Nielsen J, "A family of insulin-like growth factor II mRNAbinding proteins represses translation in late development", Mol Cell Biol, 19, pp.1262~1270 (1999)
  5. Riener MO, "IMP3 expression in lesions of the biliary tract:a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas", Hum Pathol, 40, pp.1377~1383 (2009)
  6. Schaeffer DF, "Insulin-like growth factor 2 mRNA binding protein 3(IGF2BP3)overexpression in pancreatic ductal adenocarcinoma correlates with poor survival", BMC Cancer, 10, pp.59~ (2010)
  7. Findeis-Hosey JJ, "IMP3 expression is correlated with histologic grade of lung adenocarcinoma", Hum Pathol, 41, pp.477~484 (2010)
  8. Walter O, "IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype", Hum Pathol, 40, pp.1528~1533 (2009)
  9. Li D, "IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis", Ann Surg Oncol, 16, pp.3499~3506 (2009)
  10. Noske A, "IMP3 expression in human ovarian cancer is associated with improved survival", Int J Gynecol Pathol, 28, pp.203~210 (2009)
  11. Lu D, "An oncofetal protein IMP3:a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia", Am J Surg Pathol, 33, pp.521~525 (2009)
  12. Jiang Z, "Combination of quantitative IMP3 and tumor stage:a new system to predict metastasis for patients with localized renal cell carcinomas", Clin Cancer Res, 14, pp.5579~5584 (2008)
  13. Li L, "Expression of RNA-binding protein IMP3(KOC)in benign urothelium and urothelial tumors", Hum Pathol, 39, pp.1205~1211 (2008)
  14. Jeng YM, "RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma", Hepatology, 48, pp.1118~1127 (2008)
  15. Li KH, "Expression of IMP3 in osteosarcoma and its clinical significance", Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 25, pp.426~427 (2009)
  16. Ikeda K, "IMP3", L523S,a novel immunocytochemical marker that distinguishes benign and malignant cells:the expression profiles of IMP3, Hum Pathol, pp.2010, 41[DOI]
  17. Mentrikoski MJ, "Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes", Mod Pathol, 22, pp.1582~1587 (2009)
  18. Ligato S, "KOC(K homology domain containing protein overexpressed in cancer)and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies", Diagn Cytopathol, 36, pp.561~567 (2008)
  19. Hamilton SR, "World Health Organization classification of tumors: pathology and genetics of tumors of the digestive systems", pp.158~214 (2000), IARC Press

관련 논문AI추천

Insulin-like Growth Factor II mRNA-Binding Protein 3 Expression in Benign and Premalignant Lesions and Carcinomas of the Stomach고경혁, 김동출, 송대현, 양정욱, 이정희, 이종실, 정상호대한병리학회 · Journal of Pathology and Translational Medicine2011 · 제45권 제4호IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma강유나, 박지영, 이상숙, 최미선대한병리학회 · Journal of Pathology and Translational Medicine2014 · 제48권 제2호The Significance of p53 and K-ras Immunocytochemical Staining in the Diagnosis of Malignant Biliary Obstruction by Brush Cytology during ERCP권중구, 김병석, 김은영, 김호각, 손윤경, 정진태, 한지민, Change Jae Hur, Chang-Ho Cho, Young Sup Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2010 · 제4권 제2호담관암종에서 혈청반응인자의 발현과 예후 인자로서의 의의김경렬, 김요나, 김희진, 문우성, 박신영, 박호성, 유희철, 장규윤, 정명자, 조백환대한병리학회 · Journal of Pathology and Translational Medicine2009 · 제43권 제6호Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous NeoplasmKatsuhiko Uesaka, Yasuni Nakanuma, Yuko Kakuda거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제6호Triple-Tissue Sampling during Endoscopic Retrograde Cholangiopancreatography Increases the Overall Diagnostic Sensitivity for Cholangiocarcinoma신은, 이민근, 이상협, 이승준, 이윤석, 황진혁거트앤리버 소화기연관학회협의회 · Gut and Liver2014 · 제8권 제6호

이 간행물의 다른 논문 (18건)